Results for tag: "Auranofin"

Auranofin is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is an oral gold-based medication that works by suppressing the immune system and reducing inflammation. Auranofin is a relatively new drug, having been approved by the FDA in 1985. It is generally well-tolerated, with few side effects. Auranofin is used in combination with other medications to treat immune disorders. It is often prescribed in combination with non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). Auranofin is also used to treat other conditions, such as lupus and Sjogren's syndrome. The Auranofin market is a growing one, with many companies offering the drug. Some of the companies in the market include Mylan, Teva Pharmaceuticals, and Sandoz. Other companies, such as Pfizer, Merck, and Novartis, also offer Auranofin in some countries. Show Less Read more